Tokyo, June 5, 2006 (JCN) - Takara Bio announced on June 1 that it will begin marketing two new enzymes, PrimeSTAR Max DNA Polymerase and PrimeScript, on June 18. A polymerase chain reaction (PCR) enzyme, PrimeSTAR Max DNA Polymerase has increased DNA amplification efficiency. Specifically, it can reduce the time required for amplification by 80%. Targeting the high-throughput screening and genetic testing markets, the company aims to generate annual sales of 100 million yen ($900,000).
